This page gives details of CPPsite entry with ID 2163 |
| Primary information | |
|---|---|
| CPPsite ID | 2163 |
| PEPTIDE SEQUENCE | WEARLARALARALARHLARALARA |
| PEPTIDE NAME | RALA peptide |
| CHIRALITY | L |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| CATEGORY | Amphipathic |
| N-TERMINAL MODIFICATION | Free |
| C-TERMINAL MODIFICATION | Free |
| UPTAKE EFFICIENCY | Readily traversed the plasma membrane of both cancer and fibroblast cell lines and elicited reporter-gene expression following intravenous delivery in vivo |
| PROPOSED UPTAKE MECHANISM | Endocytosis |
| INVITRO/INVIVO | In vitro and in vivo |
| CELL LINE | ZR-75-1 human breast cancer, PC-3 human prostate cancerand NCTC-929 murine fibroblast cell lines |
| CARGO | Nucleic acid (pDNA) |
| PMID | 24995949 |
| PATENT | Unknown |
| LENGTH | 24 |
| Secondary Structure | CCTTTHHHHHHHHHHHHHHHHHCC |
| SMILES | N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](Cc1nc[nH]c1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](C)CO |
| Tertiary Structure (Technique) | View in Jmol  OR Download Structure (PEPstrMOD) |